CLINICAL_TRIALS
trial_result
· 2014-06-05
Clinical Trial Update: Safety and Efficacy Study of Albiglutide in Type 2 Diabetes [Phase 3]
Summary
Phase 3 safety and efficacy study of albiglutide in adults with type 2 diabetes completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2014-06-05